More Health
Moderna’s Booster Against Omicron Variant to be Ready by Summer
By Miriam Bello - Mon, 06/13/2022 - 08:20
The Omicron variant has raised concerns about vaccine effectiveness but pharmaceuticals are working to address them.
Mosaico’s HIV Vaccine Is Being Tested in Mexico
By Sofía Garduño - Thu, 03/24/2022 - 13:18
Mosaico’s vaccine aims to prevent infection but not to cure the disease.
Pharmaceuticals Urge for Fourth COVID-19 Booster Shot
By Miriam Bello - Tue, 03/22/2022 - 12:22
Concerns of an incoming wave of Omicron subvariant BA.2 led pharmaceuticals to search for the authorization of a fourth COVID-19 shot.
Can the Developing World Spur Tech-Driven Healthcare Revolution?
By Aturo Sánchez Correa - Tue, 03/22/2022 - 11:00
The characteristic thinness of bureaucracy in the developing world gives it a healthcare edge over rich nations, writes Arturo Sanchez Correa.
January Closes with a Decrease in Omicron Cases
By Miriam Bello - Wed, 02/02/2022 - 13:03
Alliances that strengthen the sector arise but COVID-19 continues to impact the industry.
mRNA-Technology HIV Vaccine Tests Have Begun
By Alfonso Núñez - Fri, 01/28/2022 - 16:05
The HIV vaccine, which uses Moderna’s mRNA technology, began Phase I of clinical trials in the US.
Teachers’ COVID-19 Vaccine Booster Shots Delayed
By Alfonso Núñez - Fri, 01/07/2022 - 16:12
A shipment of Moderna vaccines has been unable to leave the US, delaying Mexico’s booster vaccination campaign.
COVID-19 Vaccination Efforts Continue Among Mexico’s Youth
By Alfonso Núñez - Mon, 10/25/2021 - 16:47
Pfizer vaccinations will be administered for those aged 12 to 17 beginning today.
Sweden, Denmark Suspend Moderna Shots Among Younger Groups
By Antonio Gozain - Wed, 10/06/2021 - 18:37
Shares of Moderna fell 4.9 percent in afternoon trading following the announcement of the Nordic countries’ health authorities.